Related Experiment Video
Updated: Aug 14, 2026

Semi-Automatic Graphical Tool for Measuring Coronary Artery Spatially Weighted Calcium Score from Gated Cardiac Computed Tomography Images
Published on: September 22, 2023
Effectiveness of long-term heparin-induced extracorporeal LDL precipitation (HELP) in improving coronary
A Ramunni1, L F Morrone, G Baldassarre
1Division of Nephrology, Department of Internal and Public Medicine, University of Bari, Bari, Italy. a.ramunni@libero.it
Insights
This case study shows HELP apheresis effectively lowers LDL-Cholesterol in a patient with familial hypercholesterolemia and coronary heart disease. The treatment reduced arterial calcifications and stenoses, preventing further cardiac events.
Area of Science:
- Cardiology
- Biochemistry
Background:
- Familial hypercholesterolemia (FH) is a genetic disorder characterized by high LDL-Cholesterol (LDL) levels, significantly increasing cardiovascular disease risk.
- Aggressive lipid-lowering therapy is crucial for managing high-risk hypercholesterolemic patients to reduce mortality and cardiovascular events.
Observation:
- A 51-year-old woman with heterozygous FH and coronary heart disease (CHD) presented with worsening angina.
- Despite statin therapy for ten years, her LDL-Cholesterol remained elevated, and coronary angiography revealed significant coronary artery disease.
- Following coronary bypass surgery, she underwent six years of HELP apheresis combined with statins.
Findings:
- HELP apheresis significantly reduced total cholesterol (TCHO), LDL-Cholesterol, and fibrinogen levels.
- Post-treatment measurements showed a substantial decrease in TCHO, LDL, and fibrinogen, with a slight decrease in HDL.
- Follow-up coronary angiography demonstrated the disappearance of calcifications and stable or reduced stenoses, with no further clinical manifestations of CHD.
Implications:
- HELP apheresis is a valuable therapeutic option for patients with FH and CHD who struggle to lower LDL-Cholesterol effectively.
- This treatment can lead to regression of atherosclerotic lesions and prevent recurrent cardiovascular events in high-risk individuals.
- The findings support the clinical benefit of HELP apheresis for managing severe hypercholesterolemia and associated premature coronary sclerosis.
Abstract:
There is clear clinical evidence that a drastic lowering of plasma LDL-Cholesterol (LDL) concentrations significantly reduces the rate of total and coronary mortality as well as the incidence of cardiovascular events in high risk hypercholesterolemic patients. We describe the case of a 51-year-old woman with coronary heart disease (CHD) who presented with increasing angina on exertion in 1995, at the age of 45. She suffered from a heterozygous familial hypercholesterolemia and in 1985 her total cholesterol (TCHO) was 328 +/- 62 mg/dl (mean value of ten analysis). After ten years of statins her mean values (20 analysis, 2 per year) were: TCHO 259 +/- 71, LDL 209 +/- 47, HDL 35 +/- 7 mg/dl. Coronary angiography (CA) performed in 1995 disclosed three vessel coronary heart disease with significant stenoses of the distal right coronary artery, multiple calcifications of the interventricularis artery and multiple plaques with significant stenoses in the ramus circumflexus. The woman underwent coronary by-pass surgery. Thereafter the patient was treated for six years with HELP in biweekly intervals, in combination with statins. TCHO, LDL, HDL and fibrinogen (fb) levels were measured before and after each treatment. Their mean values for an amount of 120 sessions were: TCHO pre 216 +/- 23, post 111 +/- 18 LDL pre 152 +/- 16 post 67 +/- 18, HDL pre 42 +/- 5 post 35 +/- 4 fb pre 306 +/- 48 post 125 +/- 31. In 2001 a new CA was performed. Calcifications disappeared and stenoses were identical to the previous CA or reduced. There were no further clinical manifestations of CHD. We trust that the clinical benefit of the HELP procedure will be substantial for those patients who have problems in clearing LDL from their plasma pool and who are at the same time sensitive to elevated LDL levels by the development of premature coronary sclerosis.
Related Concept Videos
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
Peripheral Artery Disease III: Interprofessional Care

